Tools

Explore

Videos Channels Figures

Atmrix

Tools

Explore

Videos Channels Figures

Atmrix

HI

Harvard Innovation Labs Cast

02/02/14

@ Harvard Innovation Labs

Our partner has a drug with liver toxicity issues, and by bringing home monitoring capabilities into play, we can help catch the 3% of patients who may experience liver toxicity.

Video

Harvard i-lab | Startup Secrets: Business Model

@ Harvard Innovation Labs

Harvard i-lab | Startup Secrets: Business Model

02/02/14

Related Takeaways

Harvard Innovation Labs Cast

02/02/14

@ Harvard Innovation Labs

Drug-induced liver injury is a leading cause of acute liver failure in the US, and monitoring liver function at home can significantly improve patient care.

Harvard Innovation Labs Cast

02/02/14

@ Harvard Innovation Labs

We're close to finalizing a strategic partnership with a major Japanese pharmaceutical company interested in home monitoring of liver function, which addresses critical needs in both developing and developed worlds.

Harvard Innovation Labs Cast

02/02/14

@ Harvard Innovation Labs

We're disrupting the way people obtain medical information and diagnostics by enabling home monitoring of liver function, eliminating the need for expensive blood draws and long wait times for results.

Harvard Innovation Labs Cast

02/02/14

@ Harvard Innovation Labs

We've validated our business model by addressing a critical need in the developing world with a simple, easy-to-use, portable liver function test, which is appealing to major pharmaceutical companies.

Scott Patterson

07/30/18

@ Y Combinator

At Notable Labs, we focus on personalized drug discovery for blood cancer by testing combinations of approved drugs on patients' actual cells.

Dr. Eric Topol

05/27/25

@ a16z

The ability to track proteins like PAL 217 can provide early warnings about cognitive impairment, which can be modified through lifestyle changes.

Patrick Hsu

04/15/25

@ Sequoia Capital

By 2050, we envision a fully automated lab capable of simulating drug interactions with high accuracy, significantly speeding up drug discovery processes.

Max Jaderberg

04/29/25

@ Sequoia Capital

At Isomorphic Labs, we collaborate with various companies to generate proprietary data, which has proven to be impactful in drug development.

Andrew Huberman

07/20/20

@ Rich Roll

The addiction treatment community needs biomarkers to identify individuals at risk of relapse early on.